Clinical trial
Multi-center, Randomized Clinical Trial of Convalescent Plasma Therapy Versus Standard of Care for the Treatment of COVID-19 in Hospitalized Patients
NCT04345523 is registered in ClinicalTrials.gov with Cristina Avendaño Solá as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-center, Randomized Clinical Trial of Convalescent Plasma Therapy Versus Standard of Care for the Treatment of COVID-19 in Hospitalized Patients
- Lead sponsor
- Cristina Avendaño Solá
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 3, 2020
- Completion date
- April 5, 2021
- Enrollment
- 350 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.